Executive functions and daily functioning in myotonic dystrophy type 1 ecological assessment with virtual reality

被引:0
|
作者
Garmendia, Joana [1 ,3 ]
Labayru, Garazi [1 ,2 ,3 ]
Aliri, Jone [1 ]
de Munain, Adolfo Lopez [2 ,3 ,4 ,5 ]
Sistiaga, Andone [1 ,2 ,3 ,6 ]
机构
[1] Univ Basque Country UPV EHU, Psychol Fac, Dept Clin & Hlth Psychol & Res Methodol, Donostia San Sebastian, Gipuzkoa, Spain
[2] Biodonostia Hlth Res Inst, Neurosci Area, Donostia San Sebastian, Gipuzkoa, Spain
[3] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[4] Donostia Univ Hosp, Neurol Dept, Donostia San Sebastian, Gipuzkoa, Spain
[5] Univ Basque Country UPV EHU, Neurosci Dept, Donostia San Sebastian, Gipuzkoa, Spain
[6] Univ Basque Country, Psychol Fac, Avda Tolosa 70, Donostia San Sebastian 20018, Gipuzkoa, Spain
关键词
DM1; Executive functions; Daily habits; Apathy; Daily performance; COGNITIVE IMPAIRMENT; DAYTIME SLEEPINESS; DYSFUNCTION; DISEASE; SIZE; PERSONALITY; PATTERN; APATHY; DM1;
D O I
10.1016/j.nmd.2023.10.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Central nervous system dysfunction is characteristic of patients with myotonic dystrophy type 1 (DM1). Although no consensus exists regarding the exact cognitive profile of these patients, executive dysfunction has been suggested to play a role. Due to the impact of executive functions on daily performance, this study aimed to describe executive functioning in an ecological manner and to analyze its impact - and that of other clinical variables - on the functional performance of DM1 patients. A Virtual Reality executive functioning test (Nesplora Ice Cream), the Wechsler Adult Intelligence Scale-Fourth Edition, and self-report questionnaires (AES, FSS, ESS and LIFE-H) were administered to 20 patients. Statistical analyses included correlation and multiple regression analyses to analyze the best predictors of daily performance. DM1 patients did not show major difficulties in the executive functioning tasks or in their overall performance on daily habits. However, both cold and hot executive functions still seem necessary for the correct accomplishment of life habits, since planning and level of apathy explained 47.6% of the total variance of daily functioning. This was the first study to assess executive functions in DM1 using Virtual Reality, and our findings open a debate about their actual impairment in this population.(c) 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:917 / 922
页数:6
相关论文
共 50 条
  • [41] Toward an appropriate neuropsychological assessment protocol for children with myotonic dystrophy type 1
    Geuens, S.
    Goemans, N.
    Thiery, E.
    Van Herck, J.
    Lemiere, J.
    De Waele, L.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S196 - S196
  • [42] PERCEIVED FUNCTIONING AND DISABILITY IN ADULTS WITH MYOTONIC DYSTROPHY TYPE 1: A SURVEY ACCORDING TO THE INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH
    Kierkegaard, Marie
    Harms-Ringdahl, Karin
    Holmqvist, Lotta Widen
    Tollback, Anna
    JOURNAL OF REHABILITATION MEDICINE, 2009, 41 (07) : 512 - 520
  • [43] Imaging of the thymus in myotonic dystrophy type 1
    Mignarri, Andrea
    Gentili, Francesco
    Masia, Francesco
    Genua, Angelo
    Cenciarelli, Silvia
    Brunori, Paola
    Mazzei, Maria Antonietta
    Malandrini, Alessandro
    Federico, Antonio
    Mazzei, Francesco Giuseppe
    Dotti, Maria Teresa
    NEUROLOGICAL SCIENCES, 2018, 39 (02) : 347 - 351
  • [44] Pain in Myotonic Muscular Dystrophy, Type 1
    Carter, Gregory T.
    Jensen, Mark P.
    Hoffman, Amy J.
    Stoelb, Brenda L.
    Abresch, Richard T.
    McDonald, Craig M.
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2008, 89 (12): : 2382 - 2382
  • [45] Cardiac abnormalities in myotonic dystrophy type 1
    Finsterer, J
    Stöllberger, C
    AMERICAN HEART JOURNAL, 2004, 148 (06)
  • [46] Molecular biomarkers in myotonic dystrophy type 1
    Slipsager, A.
    Hildonen, M.
    Stemmerik, M. Godtfeldt
    Tumer, Z.
    Duno, M.
    Birkedal, U.
    Vissing, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S155 - S155
  • [47] Urinary titin in myotonic dystrophy type 1
    Varga, David
    Perecz, Brigitta
    Fulop, Krisztina
    Sipos, Andrea
    Janszky, Jozsef Vlagyimir
    Hajdu, Nandor
    Pal, Endre
    MUSCLE & NERVE, 2023, 68 (02) : 215 - 218
  • [48] Peripheral neuropathy in myotonic dystrophy type 1
    Hermans, Mieke C. E.
    Faber, Catharina G.
    Vanhoutte, Els K.
    Bakkers, Mayienne
    De Baets, Marc H.
    de Die-Smulders, Christine E. M.
    Merkies, Ingemar S. J.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2011, 16 (01) : 24 - 29
  • [49] CUTANEOUS INNERVATION IN TYPE 1 MYOTONIC DYSTROPHY
    Manicone, M.
    Nolano, M.
    Provitera, V
    Stancanelli, A. M.
    Logullo, F.
    Provinciali, L.
    Santoro, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2012, 17 : S34 - S34
  • [50] Myotonic dystrophy type 1 - a multiorgan disease
    Orstavik, Kristin
    Solbakken, Gro
    Rasmussen, Magnhild
    Sanaker, Petter Schandl
    Fossmo, Hanne Ludt
    Bryne, Einar
    Knutsen-Oy, Torill
    Elgsas, Tonje
    Heiberg, Arvid
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (05)